Immunocore
IMCR
IMCR
133 hedge funds and large institutions have $2.63B invested in Immunocore in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 51 increasing their positions, 43 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
6% more funds holding
Funds holding: 125 → 133 (+8)
3.09% more ownership
Funds ownership: 76.82% → 79.92% (+3.1%)
Holders
133
Holding in Top 10
8
Calls
$26.7M
Puts
$5.62M
Top Buyers
| 1 | +$65.3M | |
| 2 | +$59.6M | |
| 3 | +$28.9M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.3M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$25.6M |
Top Sellers
| 1 | -$31.9M | |
| 2 | -$31.5M | |
| 3 | -$30M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$20.2M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$19.3M |